R. Andrew Chambers

5.6k total citations · 1 hit paper
60 papers, 4.0k citations indexed

About

R. Andrew Chambers is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, R. Andrew Chambers has authored 60 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cellular and Molecular Neuroscience, 18 papers in Cognitive Neuroscience and 14 papers in Molecular Biology. Recurrent topics in R. Andrew Chambers's work include Neurotransmitter Receptor Influence on Behavior (24 papers), Neuroscience and Neuropharmacology Research (17 papers) and Memory and Neural Mechanisms (11 papers). R. Andrew Chambers is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (24 papers), Neuroscience and Neuropharmacology Research (17 papers) and Memory and Neural Mechanisms (11 papers). R. Andrew Chambers collaborates with scholars based in United States, United Kingdom and Japan. R. Andrew Chambers's co-authors include Marc N. Potenza, Jane R. Taylor, Teige P. Sheehan, David Russell, John H. Krystal, David W. Self, Barbara K. Lipska, Kuei Y. Tseng, Susan K. Conroy and Willard L. Miranker and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

R. Andrew Chambers

59 papers receiving 3.8k citations

Hit Papers

Developmental Neurocircuitry of Motivation in Adolescence... 2003 2026 2010 2018 2003 400 800 1.2k

Peers

R. Andrew Chambers
Bryon Adinoff United States
Andrew J. Lawrence United Kingdom
Mary‐Anne Enoch United States
Joseph F. Cubells United States
Scott D. Moore United States
Patrick K. Randall United States
Ronald L. Cowan United States
Helen Fox United Kingdom
Kelly Cosgrove United States
Ina Giegling Germany
Bryon Adinoff United States
R. Andrew Chambers
Citations per year, relative to R. Andrew Chambers R. Andrew Chambers (= 1×) peers Bryon Adinoff

Countries citing papers authored by R. Andrew Chambers

Since Specialization
Citations

This map shows the geographic impact of R. Andrew Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Andrew Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Andrew Chambers more than expected).

Fields of papers citing papers by R. Andrew Chambers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Andrew Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Andrew Chambers. The network helps show where R. Andrew Chambers may publish in the future.

Co-authorship network of co-authors of R. Andrew Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of R. Andrew Chambers. A scholar is included among the top collaborators of R. Andrew Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Andrew Chambers. R. Andrew Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Chambers, R. Andrew, et al.. (2015). Pseudoaddiction: Fact or Fiction? An Investigation of the Medical Literature. Current Addiction Reports. 2(4). 310–317. 33 indexed citations
4.
Engleman, Eric A., et al.. (2014). Nicotine is more addictive, not more cognitively therapeutic in a neurodevelopmental model of schizophrenia produced by neonatal ventral hippocampal lesions. Publisher. 2 indexed citations
5.
Lapish, Christopher C., et al.. (2014). Selective Effects of D- and L-Govadine in Preclinical Tests of Positive, Negative, and Cognitive Symptoms of Schizophrenia. Neuropsychopharmacology. 39(7). 1754–1762. 16 indexed citations
6.
Brown, Ashley M., et al.. (2014). Prescription Drug Monitoring Program Inquiry in Psychiatric Assessment. The Journal of Clinical Psychiatry. 75(7). 750–756. 12 indexed citations
7.
Herrold, Amy A., Neil Jordan, Walter M. High, et al.. (2014). Alcohol use and craving among Veterans with mental health disorders and mild traumatic brain injury. The Journal of Rehabilitation Research and Development. 51(9). 1397–1410. 4 indexed citations
8.
Chambers, R. Andrew. (2013). The Addiction Psychiatrist as Dual Diagnosis Physician: A Profession in Great Need and Greatly Needed. Journal of Dual Diagnosis. 9(3). 260–266. 8 indexed citations
10.
Chambers, R. Andrew, et al.. (2010). The Dual Diagnosis Physician-infrastructure Assessment Tool: Examining Physician Attributes and Dual Diagnosis Capacity. Psychiatric Services. 61(2). 184–188. 4 indexed citations
11.
Czachowski, Cristine L., et al.. (2010). Alcohol seeking and consumption in the NVHL neurodevelopmental rat model of schizophrenia. Behavioural Brain Research. 218(2). 346–349. 21 indexed citations
12.
Chambers, R. Andrew, et al.. (2009). Cortical-Striatal Integration of Cocaine History and Prefrontal Dysfunction in Animal Modeling of Dual Diagnosis. Biological Psychiatry. 67(8). 788–792. 31 indexed citations
13.
Chambers, R. Andrew & Susan K. Conroy. (2007). Network Modeling of Adult Neurogenesis: Shifting Rates of Neuronal Turnover Optimally Gears Network Learning according to Novelty Gradient. Journal of Cognitive Neuroscience. 19(1). 1–12. 86 indexed citations
14.
Wiegand, Ryan E., et al.. (2006). Huntington disease as a dual diagnosis disorder: Data from the national research roster for Huntington disease patients and families. Drug and Alcohol Dependence. 86(2-3). 283–286. 15 indexed citations
15.
Conroy, Susan K., Zachary A. Rodd, & R. Andrew Chambers. (2006). Ethanol sensitization in a neurodevelopmental lesion model of Schizophrenia in rats. Pharmacology Biochemistry and Behavior. 86(2). 386–394. 37 indexed citations
16.
Chambers, R. Andrew, Rachel Jones, Scott Brown, & Jane R. Taylor. (2004). Natural reward-related learning in rats with neonatal ventral hippocampal lesions and prior cocaine exposure. Psychopharmacology. 179(2). 470–478. 23 indexed citations
17.
Chambers, R. Andrew & Marc N. Potenza. (2003). Neurodevelopment, Impulsivity, and Adolescent Gambling. Journal of Gambling Studies. 19(1). 53–84. 247 indexed citations
18.
Chambers, R. Andrew, Jane R. Taylor, & Marc N. Potenza. (2003). Developmental Neurocircuitry of Motivation in Adolescence: A Critical Period of Addiction Vulnerability. American Journal of Psychiatry. 160(6). 1041–1052. 1211 indexed citations breakdown →
19.
Chambers, R. Andrew, Marc N. Potenza, Ralph E. Hoffman, & Willard L. Miranker. (2003). Simulated Apoptosis/Neurogenesis Regulates Learning and Memory Capabilities of Adaptive Neural Networks. Neuropsychopharmacology. 29(4). 747–758. 125 indexed citations
20.
Chambers, R. Andrew, John H. Krystal, & David W. Self. (2001). A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry. 50(2). 71–83. 387 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026